Explore
Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration
0 Ungluers have
Faved this Work
Login to Fave
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 50 times via unglue.it ebook links.
- 50 - pdf (CC BY) at Unglue.it.
Keywords
- aflibercept
- aflibercept monotherapy
- age-related macular degeneration
- age-related macular degeneration (AMD)
- AMD
- Angiogenesis
- anti-vascular endothelial growth factor
- anti-VEGF
- anti-VEGF treatment
- anti–vascular endothelial growth factor
- AREDS2-HOME study
- arterial hypertension
- bevacizumab
- brolucizumab
- cardiovascular risk factors
- cataract surgery
- choriocapillaris
- choroidal neovascularisation
- choroidal neovascularization
- clinical trials
- comparative therapies
- Delphi
- disease activity
- effectiveness
- emerging treatment
- epithelial tear
- exudation
- fellow eye
- food supplement
- ForeseeHome AMD Monitoring System®
- good baseline visual acuity
- hereditary retinal dystrophy
- Identification
- intravitreal anti-vascular endothelial growth factor
- lifestyle
- long-term FU
- macula-off rhegmatogenous detachment
- macular neovascularization
- medicine
- Meta-analysis
- meta-regression
- meteorin
- n/a
- neovascular age-related macular degeneration
- neovascular age-related macular degeneration (nAMD)
- Nutrients
- oct-angiography
- Optical Coherence Tomography
- optical coherence tomography angiography
- polypoidal choroidal vasculopathy
- Prevention
- pro re nata regimen
- quiescent macular neovascularization
- ranibizumab
- reading acuity
- real-world evidence
- Retina
- retinal deep perifoveal capillary plexus
- Risk
- Sorsby
- Sorsby’s fundus dystrophy
- STARS®
- superficial perifoveal capillary plexus
- switch therapy
- therapeutic innovation
- treat and extend
- treat-and-extend
- treatment change
- Treatment Outcome
- treatment-naive
- vascular endothelial growth factor (VEGF)
- visual acuity
Links
DOI: 10.3390/books978-3-0365-3929-4Editions